Is muscle strength an overlooked parameter in patients affected by mild autonomous cortisol secretion? - Scorecard - MDSpire

Is muscle strength an overlooked parameter in patients affected by mild autonomous cortisol secretion?

  • By

  • Martina Romanisio

  • Chiara Mele

  • Sara Sturnia

  • Carola Ciamparini

  • Rosa Pitino

  • Alice Ferrero

  • Lorenza Scotti

  • Madalina Elena Iftimie

  • Gianluca Aimaretti

  • Paolo Marzullo

  • Flavia Prodam

  • Marina Caputo

  • April 30, 2026

  • 0 min

Share

Clinical Scorecard: Is Muscle Strength an Underappreciated Factor in Patients with Mild Autonomous Cortisol Secretion?

At a Glance

CategoryDetail
ConditionMild Autonomous Cortisol Secretion (MACS)
Key MechanismsMild hypercortisolism linked to skeletal muscle atrophy and weakness through reduced protein synthesis, activation of proteolytic pathways, mitochondrial dysfunction, and impaired neuromuscular transmission.
Target PopulationPatients with adrenal incidentalomas associated with MACS.
Care SettingEndocrinology Unit, Hospital setting.

Key Highlights

  • Higher prevalence of osteopenia and osteoporosis in MACS patients (61.9%) compared to NFAA (28.6%) and controls (25%).
  • Significantly reduced muscle strength in MACS patients as assessed by MRC scores.
  • Quality of life scores trend toward greater impairment in MACS group.
  • No significant differences in fat-free mass, muscle mass, or fat mass among groups.
  • MACS patients exhibit higher post-dexamethasone suppression test cortisol concentrations.

Guideline-Based Recommendations

Diagnosis

  • Classify patients with post-DST cortisol levels >1.8 µg/dL as having MACS.

Management

  • Consider adrenalectomy for selected patients with MACS to improve cardiometabolic outcomes.

Monitoring & Follow-up

  • Regular assessment of muscle strength and quality of life in patients with MACS.

Risks

  • Increased risk of frailty and adverse health outcomes associated with prolonged exposure to subclinical cortisol excess.

Patient & Prescribing Data

Adults with newly diagnosed non-aldosterone-producing adrenocortical adenomas (NAPACAs).

Potential improvement in selected cardiometabolic outcomes after adrenalectomy in carefully selected patients.

Clinical Best Practices

  • Integrate body composition analysis and functional assessments in routine evaluations of patients with MACS.
  • Utilize validated tools for assessing frailty and muscle strength.

References

Original Source(s)

Related Content